Package Leaflet: Information for the User
Tiorfan 100 mg Hard Capsules
racecadotril
Read all of this leaflet carefully before you start taking this medicine.
Contents of the pack:
Tiorfan is a medicine for the treatment of diarrhea.
Tiorfan is used to treat the symptoms of acute diarrhea in adults, when the causes of diarrhea cannot be treated.
If causal treatment is possible, racecadotril may be administered as complementary treatment.
Do not take Tiorfan
Warnings and precautions
Consult your doctor or pharmacist before taking Tiorfan if:
Racecadotril, the active substance of Tiorfan, may cause an allergic reaction called angioedema, which can cause swelling of the face, lips, throat, or tongue. If you experience these side effects, stop treatment immediately and contact your doctor. Swelling can occur at any time during treatment with this product.
Concomitant use of this product and other medicines may increase the risk of angioedema (see "Other medicines and Tiorfan").
Skin reactions have been reported with the use of this product. In most cases, they are mild and do not require treatment. In some cases, severe skin reactions may occur. In these cases, treatment with Tiorfan should be stopped immediately and the patient should not take it again.
Severe skin reactions, including drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported in association with treatment with racecadotril. Stop using racecadotril and seek medical attention immediately if you notice any of the symptoms related to these severe skin reactions described in section 4.
Using Tiorfan with other medicines
Please inform your doctor if you are using, have recently used, or might use any other medicines.
Especially inform your doctor if you are taking any of the following medicines, as they may increase the risk of side effects (see "Warnings and precautions"):
Pregnancy and breastfeeding
Tiorfan is not recommended if you are pregnant or think you may be pregnant, or if you are breastfeeding.
Consult your doctor or pharmacist before taking any medicine.
Driving and using machines
Tiorfan has little or no effect on the ability to drive or use machines.
Tiorfan contains lactose
Tiorfan contains lactose (a type of sugar). If your doctor has told you that you have an intolerance to some sugars, ask your doctor before taking Tiorfan.
This medicine does not contain gluten.
Follow the instructions for administration of this medicine exactly as indicated by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.
The usual dose is one capsule three times a day, which should be swallowed with a glass of water.
Tiorfan is presented in the form of hard capsules.
The usual dose is one capsule three times a day, which should be swallowed with a glass of water. Tiorfan should be taken preferably before main meals, but to start treatment, you can take a Tiorfan capsule at any time of the day.
Your doctor will indicate the duration of treatment with Tiorfan. Treatment should be maintained until two normal stools are produced, not exceeding 7 days.
To compensate for fluid loss due to diarrhea, this medicine should be used along with adequate fluid and electrolyte replacement. The best replacement of fluids and salts is achieved with an oral rehydration solution (please ask your doctor or pharmacist if you are unsure).
No dose adjustment is required in the elderly.
Children
For use in children and infants, other forms of Tiorfan are available.
If you take more Tiorfan than you should
If you take more Tiorfan than you should, please contact your doctor or pharmacist immediately.
If you forget to take Tiorfan
Do not take a double dose to make up for a forgotten dose. Simply continue with the treatment.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Stop taking Tiorfan and contact a doctor immediately if you experience symptoms of angioedema, such as:
Stop using racecadotril and seek medical attention immediately if you notice any of the following symptoms:
The following side effects have been reported:
Common (may affect up to 1 in 10 people): headache.
Uncommon (may affect up to 1 in 100 people): rash and erythema (redness of the skin).
Frequency not known (frequency cannot be estimated from the available data): erythema multiforme (red lesions on the extremities and inside the mouth), tongue swelling, facial swelling, lip swelling, eyelid swelling, urticaria, erythema nodosum (inflammation in the form of lumps under the skin), papular rash (rash on the skin with small, hard, and raised lesions), prurigo (lesions on the skin with itching), pruritus (generalized itching), and toxic skin rash.
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Monitoring System (www.notificaram.es). By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton after EXP.
The expiry date is the last day of the month stated.
No special storage conditions are required.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of Tiorfan
The active substance is racecadotril. Each capsule contains 100 mg of racecadotril.
The other ingredients are lactose, pregelatinized corn starch, magnesium stearate, and anhydrous colloidal silica. The capsule contains gelatin, yellow iron oxide (E 172), and titanium dioxide (E 171).
Appearance of Tiorfan and contents of the pack
Tiorfan is presented in the form of hard ivory-colored capsules.
Each pack contains 6, 10, 20, 100, or 500 hard capsules. The 100 and 500 capsule packs are for hospital use only.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
BIOPROJET-FERRER, S.L.
Gran Vía Carlos III, 94
08028 Barcelona (Spain)
Manufacturer
FERRER INTERNACIONAL, S.A.
Joan Buscallà 1-9
08173 Sant Cugat del Vallès, Barcelona (Spain)
or
SOPHARTEX,
21 rue de Pressoir,
28500 Vernouillet (France)
This medicine is authorized in the Member States of the European Economic Area under the following names:
GERMANY: Tiorfan
PORTUGAL: Tiorfan
GREECE: Hidrasec
ITALY: Tiorfix
AUSTRIA: Hidrasec
BELGIUM: Tiorfix
CZECH REPUBLIC: Hidrasec
DENMARK: Hidrasec
ESTONIA: Hidrasec
FINLAND: Hidrasec
HUNGARY: Hidrasec
IRELAND: Hidrasec
LATVIA: Hidrasec
LITHUANIA: Hidrasec
LUXEMBOURG: Tiorfix
NETHERLANDS: Hidrasec
POLAND: Tiorfan
SLOVAKIA: Hidrasec
SLOVENIA: Hidrasec
SWEDEN: Hidrasec
UNITED KINGDOM: Hidrasec
This leaflet was approved on 24-11-2024
Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) www.aemps.gob.es.